REVAMMAD · Retinal Vascular Modeling, Measurement and Diagnosis""
FP7 — People (Marie Curie Actions)
- Duration
- 2013-04-01 → 2017-03-31
- EU contribution
- €3,768,601
- Participants
- 10
- Scheme
- MC-ITN
Lines connect the coordinator with its partners.
Results in brief
Retinal Vascular Modeling, Measurement and Diagnosis
The REtinal VAscular Modeling, Measurement And Diagnosis (REVAMMAD) project addressed the problem of diagnosing some of the most globally significant chronic medical conditions and vascular diseases including diabetes, hypertension, dementia and stroke, by focusing on the detailed analyses of changes caused to the blood vessels by utilising images taken from the retina. The project engaged a wide range of expertise, from mathematical modellers and clinicians to computer vision experts, who collaboratively worked across countries and across the boundaries of individual disciplines to train a new generation of interdisciplinary scientists. As a result of their participation in the REVAMMAD project, our Early Stage Researchers (ESRs) have been given the opportunities to gain new skills which have enabled them to effectively translate the latest vascular modelling theory and computerised image analysis techniques into effective interventions. Our researchers investigated changes to the walls of the blood vessels of the retina caused by vascular disease, engaging with patients who have pre-diabetic retinopathy to track the changes caused to the retina vessels, effectively mapping the journey of progression to retinopathy through studying these vessels. This gave our researchers the opportunity to develop a range of new techniques which enabled them to both accurately detect the retinal vasculature, and to extract precise measurements from it. New techniques in mathematical modelling were developed and validated by our researchers, including the modelling of myogenic response gradients throughout the retinal vessel network, modelling how vessel walls respond to changes in blood flow under stimuli, and how whole vessel networks behave. These advances have been synergistically combined with our advancements in computer vision techniques which themselves have shed new light on how we are able to detect the individual parts of the retina, generating significant new data. This bringing together of disciplines has enabled us to utilise the overlap of mathematical modelling and computer vision in the study of flow dynamics within retinal blood vessels, which in turn increases our understanding of how these vessels are actually connected. We have also developed “risk models” to optimise the screening intervals for patients with diabetic retinopathy, involving input from clinicians in determining the role of computerised analysis of the retina in support of this advancement. A fully automated system to estimate the degree of narrowing, bulging or tortuosity (‘curving’) of blood vessels was developed, both in terms of modelling the curvilinear structures and the learning context filters. Using a novel approach to accelerated convolutional sparse coding filter learning, this new methodology is expected to make filter learning much more discriminative and will result in a more robust segmentation module. The tortuosity plane has been proposed as a better tool to quantify and interpret tortuosity. The curvature enhancement method has allowed for a new set of tortuosity metrics to be created. The progression from diabetes to diabetic retinopathy is associated with changes in retinal haemodynamics (i.e. the dynamics of blood flow as it adjusts to the conditions within the body and its environment). We analysed longitudinal studies of 24 subjects for the three years preceding the appearance of diabetic retinopathy, estimated fluidynamic parameters using a simple haemodynamic model, and established statistically significant changes in some estimated haemodynamic parameters associated with the development of diabetic retinopathy. We developed a new algorithm for the automatic detection of optic nerve hypoplasia (ONH), a congenital optical nerve anomaly resulting in the underdevelopment of the optic nerve. Our algorithm was demonstrated to be the fastest and second best performing in the world compared to current literature, when tested on the MESSIDOR dataset - a collection of diabetic retinopathy examinations, each consisting of two macula-centred eye fundus images (one per eye). Qualitative results are shown to improve with an elliptical approximation of the ONH boundary; this was enabled by modelling the photograph distortion caused by the quasi-spherical shape of the eye. We also developed probabilistic models which relate the location of retinal lesions to clinical risk, using a prospective database of 60 patients recorded over 10 years, with 900 images. Special analysis tools were developed in the project which have shown a strong relationship between the area where micro aneurysms appear, and the development of disease. Vascular disease and chronic medical conditions such as Alzheimer’s, diabetes, stroke and coronary heart disease account for an increasingly large proportion of healthcare costs across European member states. As a result of the research carried out in the REVAMMAD project, the new and improved methodologies and algorithms will feed into the future development of computerised screening systems to enable earlier diagnosis of disease, and improvements to both treatment and ultimately outcomes, ultimately benefitting both the economy and society as a whole. The project generated a significant number of software tools and datasets which can house relevant data, including images and clinical assessments to be deposited by clinicians and scientists working in the field, together with software components for mathematical modelling and computerised imagery analysis. In addition to making these software components publicly available to support the advancement of research in this field, the projects partners are looking at other ways to commercially exploit this software. The programme was most notably successful in achieving its core objective to provide a high quality interdisciplinary training programme. As a result of their participation in the project, the researchers developed into a strong cohort with a good, shared ethos and deep levels of collaboration and co-operation across the project. The core of the programme was the series of five extensive workshops held during the project: two at the University of Lincoln; one at FORTH in Crete; one at Charite in Berlin, and one at Padova in Italy. Each of the workshops combined taught activities, some of which were introduced by leading international experts in the field from outside the consortium, and additional skills such as media training (for outreach activities, and career preparation), research presentations and identification of research goals. These workshops were complemented by an extensive series of secondments, participated in by all of the researchers (most of whom experienced more than one secondment). These secondments enabled knowledge and expertise transfer and facilitated the development of collaboration between laboratories. The cohort’s connectivity was reinforced by regular events such as e-seminars and discussions and by other joint dissemination and information-sharing tools, such as blogs, which were organised and operated by the ESRs themselves. Our ESRs, having benefited from the intense training and supervision in REVAMMAD, have gone on to establish scientific and academic careers as lecturers and researchers and in scientific companies. Almost all registered for PhDs, either having already completed, or are approaching completion, of their studies. Websites: Project Website: https://revammad.blogs.lincoln.ac.uk/ Project Outreach blog (maintained by ESRs): https://revammad.wordpress.com/ Contact details: REVAMMAD Coordinator: Professor Andrew Hunter, Deputy Vice Chancellor Research and Innovation, University of Lincoln REVAMMAD Project Manager: Pilar Pousada Solino, University of Lincoln (ppousadasolino@lincoln.ac.uk) 01522 835087
Data: CORDIS, © European Union
Project objective
The REtinal VAscular Modeling, Measurement And Diagnosis (REVAMMAD) project will train a new generation of scientists able to effectively translate the latest vascular modeling theory and computerized image analysis techniques into effective interventions for some of the most important chronic medic conditions afflicting the EU, including hypertension and diabetes. It will particularly ensure that there is rich clinical and industrial involvement to ensure that the training is focused with end-users and exploitation in mind.The vasculature undergoes changes in response to early stages of these diseases, reflecting fundamental physiological processes within the vessels.The retina provides a unique “window onto the vasculature,” allowing it to be viewed and measurements made in vivo, and advances in imaging technologies make it increasingly possible to measure subtle changes using computer vision algorithms, including through routine medical checks such as eye tests.The field is currently fragmented, with many excellent pockets of collaboration focused on defined specialisms, particularly between clinicians and modelers, or clinicians and measurement specialists, but lacking overall structure. Despite the importance and incidence of the diseases and the evidence for the possibility of better diagnosis through imaging, there has been relatively little translation of theory into clinical practice.Integrative action is required to train researchers who understand the medical, clinical, technological and commercial aspects of the problem domain and to establish common working methodologies and tools across the field. REVAMMAD will train early careers researchers who combine these skills in order to motivate the introduction of high impact interventions in the future.""
Original text from CORDIS.
Participants
- UNIVERSITY OF LINCOLN · LincolnCoordinatorUnited Kingdom
- AARHUS UNIVERSITETSHOSPITAL · AarhusDenmark
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN · BerlinGermany
- HEALTH INTELLIGENCE LTD · SANDBACHUnited Kingdom
- IDRYMA TECHNOLOGIAS KAI EREVNAS · IRAKLEIOGreece
- INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE · Le Chesnay CedexFrance
- KOBENHAVNS UNIVERSITET · KOBENHAVNDenmark
- OROBIX SRL · BergamoItaly
- UNIVERSITA DEGLI STUDI DI PADOVA · PadovaItaly
- UNIVERSITY OF DUNDEE · DundeeUnited Kingdom
Links
- View on CORDIS
- https://ec.europa.eu/research-and-innovation/en/projects/success-stories/all/eye-scans-provide-early-warning-chronic-disease
Data: CORDIS, © European Union
